Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Interferon modifies morphine withdrawal phenomena in rodents.

Neuropharmacology

|May 1, 1983

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Age differences to methylphenidate-NAc neuronal and behavioral recordings from freely behaving animals.

Journal of neural transmission (Vienna, Austria : 1996)·2022

Same author

Adolescent rats respond differently to methylphenidate as compared to adult rats- concomitant VTA neuronal and behavioral Recordings.

Brain research bulletin·2022

Same author

Adult female rats' altered diurnal locomotor activity pattern following chronic methylphenidate treatment.

Journal of neural transmission (Vienna, Austria : 1996)·2013

Same author

Adolescent rat circadian activity is modulated by psychostimulants.

Brain research·2011

Same author

Psychostimulants given in adolescence modulate their effects in adulthood using the open field and the wheel-running assays.

Brain research bulletin·2010

Same author

Bilateral six-hydroxydopamine administration to PFC prevents the expression of behavioral sensitization to methylphenidate.

Brain research·2009

Interferon injections significantly reduced withdrawal symptoms in morphine-dependent rats. This finding suggests interferon may decrease the liability of developing opiate addiction.

Area of Science:

Neuroscience
Pharmacology
Addiction Research

Background:

Opioid dependence is a major public health concern.
Naloxone is a standard treatment for opioid overdose and withdrawal.
Interferon's role in addiction is not well understood.

Purpose of the Study:

To investigate the effect of interferon on morphine withdrawal symptoms in rats.
To determine if interferon can reduce the liability of developing opiate addiction.

Main Methods:

Morphine-dependent rats were treated with interferon before naloxone administration.
Behavioral signs of withdrawal were monitored.
Interferon was administered prior to chronic morphine treatment to assess addiction liability.

Related Experiment Videos

Main Results:

Interferon injection prior to naloxone eliminated 7 key behavioral signs of withdrawal.
A single interferon dose before chronic morphine treatment reduced the rats' liability to opiate addiction.

Conclusions:

Interferon shows potential in mitigating opioid withdrawal symptoms.
Interferon may serve as a novel therapeutic agent for reducing opiate addiction liability.